Simplex Trading
IGMS

Simplex Trading’s IGM Biosciences IGMS Stock Holding History

Simplex Trading’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$1K – 9297
2023
Q4 		$1K Buy
+200
New +$1.16K ﹤0.01% 8503
2023
Q2 		– Sell
-100
Closed -$1K – 9403
2023
Q1 		$1K Sell
100
-100
-50% -$2.07K ﹤0.01% 8706
2022
Q4 		$3K Sell
200
-700
-78% -$14K ﹤0.01% 8372
2022
Q3 		$20K Buy
+900
New +$18.2K ﹤0.01% 7519
2022
Q2 		– Sell
-81,800
Closed -$2.19M – 10440
2022
Q1 		$2.19M Buy
81,800
+81,700
+81,700% +$1.52M ﹤0.01% 2023
2021
Q4 		$2K Sell
100
-100
-50% -$4.97K ﹤0.01% 9997
2021
Q3 		$17K Hold
200
– – ﹤0.01% 8563
2021
Q2 		$16K Buy
200
+184
+1,150% +$13.6K ﹤0.01% 8767
2021
Q1 		$122K Sell
16
-6
-27% -$546 ﹤0.01% 5455
2020
Q4 		$194K Buy
22
+19
+633% +$1.34K ﹤0.01% 4648
2020
Q3 		$22K Buy
+3
New +$178 ﹤0.01% 6296

Other funds holding IGMS

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's IGMS Position: Q1 2025 in Review

Simplex Trading sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 561 shares — an estimated $1.04K sold.

Simplex Trading first reported a position in IGMS in Q3 2020 and held it in 8 quarters. The position peaked at $722K in Q3 2022. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Simplex Trading reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 561 IGM Biosciences shares in Q1 2025, an estimated $1.04K.
  • Simplex Trading first reported a position in IGM Biosciences in Q3 2020 and held it in 8 quarters.
  • Simplex Trading's IGM Biosciences position peaked at $722K in Q3 2022.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.